降低风险输卵管卵巢切除术中常规腹膜与大网膜活检的作用
回顾性观察队列纳入2003年1月至2016年6月在单一机构因BRCA1/2高危突变或缺失行降低风险输卵管卵巢切除术的70例女性,评估腹膜与大网膜活检的价值。所有大网膜与腹膜活检均未发现非典型间皮增生或癌,盆腔冲洗液仅1例(1.7%)见倾向反应性的罕见非典型细胞。作者认为常规腹膜与大网膜活检似乎不提高隐匿性恶性肿瘤的检出。
要点
- 70例中3例在输卵管远端发现浆液性输卵管上皮内癌。
- 所有大网膜与腹膜活检均未见非典型间皮增生或癌。
- 常规腹膜与大网膜活检似乎不改善隐匿性恶性肿瘤的检出。
核心结论
- 对行降低风险输卵管卵巢切除术的女性,常规腹膜与大网膜活检似乎不提高隐匿性恶性肿瘤的检出。
研究设计与样本
- 回顾性观察队列(加拿大工作组分类II.1),研究场所为学术性妇科执业机构。
- 纳入2003年1月至2016年6月在单一机构因BRCA1/2高危突变或缺失行降低风险输卵管卵巢切除术的全部女性,共70例。
- 双侧输卵管采用「切片并广泛检查伞端」方案进行组织学评估,采用描述性统计总结结果。
主要发现
- 70例中60%(n=42)携带BRCA1高危突变,37.1%(n=26)携带BRCA2高危突变,2.9%(n=2)经BRAC分析重排检测(BART)发现BRCA高危缺失。
- 3例在输卵管远端发现浆液性输卵管上皮内癌。
- 除降低风险输卵管卵巢切除术外,受试者接受盆腔冲洗(n=58,82.9%)、大网膜活检(n=44,62.9%)、双侧结肠旁沟腹膜活检(n=51,72.9%)、前后陷凹活检(n=53,75.7%)及直肠乙状结肠系膜活检(n=11,15.7%)。
- 1例(1.7%)输卵管组织学正常者的盆腔冲洗液中发现倾向反应性细胞的罕见非典型细胞;所有大网膜与腹膜活检均未发现非典型间皮增生或癌。
- 平均随访32.5±24.7个月,末次接触时3例(4.3%)死于转移性乳腺癌,另3例(4.3%)诊断乳腺癌复发,其余受试者均存活且状况良好(n=64,91.4%)。
临床怎么用
- 作者认为,对行降低风险输卵管卵巢切除术的女性,常规腹膜与大网膜活检似乎不提高隐匿性恶性肿瘤的检出。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: To assess the potential role of peritoneal and omental biopsies in women undergoing risk-reducing salpingo-oopherectomy (RRSO) for prophylactic management of hereditary breast/ovarian cancer (HBOC) syndromes. DESIGN: A retrospective observational cohort (Canadian Task Force classification II.1). SETTING: An academic gynecology practice. PATIENTS: All women who underwent RRSO for a high-risk BRCA1/2 mutation or deletion at a single institution between January 2003 and June 2016. INTERVENTIONS: After obtaining institutional review board approval, patient demographics, types of surgical intervention, histopathology reports, and outcomes were abstracted. Bilateral fallopian tubes were histologically evaluated using the "sectioning and extensively examining of the fimbriated end" protocol. Descriptive statistics were used to summarize findings. MEASUREMENTS AND MAIN RESULTS: Seventy women underwent RRSO within the study window; 60% (n = 42) carried a high-risk mutation in BRCA1, 37.1% (n = 26) carried a high-risk mutation in BRCA2, and 2.9% (n = 2) had a high-risk BRCA deletion identified by BRAC analysis rearrangement testing (BART). Serous tubal intraepithelial carcinomas were identified in the distal fallopian tube of 3 subjects. In addition to RRSO, subjects underwent pelvic washings (n = 58, 82.9%), omental biopsy (n = 44, 62.9%), peritoneal biopsies of the bilateral paracolic gutters (n = 51, 72.9%), anterior and posterior cul-de-sac (n = 53, 75.7%), and rectosigmoid mesentery (n = 11, 15.7%). Rare atypical cells favoring reactive cells were identified in pelvic washings of 1 subject (1.7%) with histologically normal fallopian tubes. No evidence of atypical mesothelial proliferations or carcinoma was identified in any omental or peritoneal biopsies. The mean duration of follow-up was 32.5 ± 24.7 months. At the last contact, 3 women (4.3%) had died of metastatic breast cancer, whereas another 3 (4.3%) had been diagnosed with a recurrence of their breast cancer. All other subjects were alive and well (n = 64, 91.4%). CONCLUSION: The routine use of peritoneal and omental biopsies for women undergoing RRSO does not appear to improve detection of occult malignancy.
引用
- Miller H, Pipkin LS, Tung C, et al. The Role of Routine Peritoneal and Omental Biopsies at Risk-Reducing Salpingo-Oophorectomy. J Minim Invasive Gynecol. 2017. PMID: 28285055. doi:10.1016/j.jmig.2017.03.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。